" class="no-js "lang="en-US"> Respiratory Archives - Page 2 of 2 - Medtech Alert
Friday, September 05, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors

Sort by:

Date

Top Post

Pfizer Announces Start of Phase 3 Clinical Trial in Adults for its Investigational Vaccine Against Respiratory Syncytial Virus (RSV) | Pharmtech Focus

Pfizer Announces Start of Phase 3 Clinical Trial in Adults for its Investigational Vaccine Against Respiratory Syncytial Virus (RSV)

Pfizer Inc. (NYSE:PFE) today announced the initiation of RENOIR (RSV vaccine Efficacy study iNOlder adults Immunized against RSV […]

Read more

Diseases

 NuvoAir Respiratory Platform Shows Promise for Long-Term Remote Monitoring of Asthma | Pharmtech Focus

NuvoAir Respiratory Platform Shows Promise for Long-Term Remote Monitoring of Asthma

Three new studies show how home monitoring technology – developed by leading digital health company NuvoAir – […]

Diseases

 Rising Demand for Needle-free Vaccines to Drive Innovation in the Respiratory Virus Vaccines Market | Pharmtech Focus

Rising Demand for Needle-free Vaccines to Drive Innovation in the Respiratory Virus Vaccines Market

A vaccination refers to a biological product that is utilized to provide acquired immunity against a […]

Diseases

 Tezepelumab Regulatory Submission Accepted and Granted FDA Priority Review in the US for the Treatment of Patients with Asthma | Pharmtech Focus

Tezepelumab Regulatory Submission Accepted and Granted FDA Priority Review in the US for the Treatment of Patients with Asthma

AstraZeneca’s Biologics License Application (BLA) for tezepelumab has been accepted and granted Priority Review for […]

Diseases

 NuvoAir Raises $12M in Series A Funding to Improve the Care of Millions Suffering From Lung Conditions | Pharmtech Focus

NuvoAir Raises $12M in Series A Funding to Improve the Care of Millions Suffering From Lung Conditions

NuvoAir – the digital health company on a mission to improve the lives of millions […]

Diseases

 Hephaï Files Software Patent for its Digital Education Platform Designed to Improve Patient Inhaler Use | Pharmtech Focus

Hephaï Files Software Patent for its Digital Education Platform Designed to Improve Patient Inhaler Use

Hephaï, a French start-up developing an AI-based digital education platform, today announces that it has […]

Diseases

 Amgen Announces Tezepelumab Biologics License Application Submitted To U.S. FDA | Pharmtech Focus

Amgen Tezepelumab BLA Submitted to U.S. FDA

Amgen (NASDAQ:AMGN) today announced its partner AstraZeneca (NASDAQ:AZN) submitted a Biologics License Application (BLA) to […]

Diseases

 Research Presented at RDD 2021 Suggests That Acoustic Technology Is a Viable Alternative to High-cost Electronic Smart Inhalers | Pharmtech Focus

Research Presented at RDD 2021 Suggests That Acoustic Technology Is a Viable Alternative to High-cost Electronic Smart Inhalers

Research presented at the Respiratory Drug Delivery (RDD) 2021 conference suggests that inhalers using acoustic […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients

    Clinical Trials

     Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS

    Clinical Trials

     Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board

    Appointments

     Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera

    News

     Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic

    Clinical Trials

     Read more